论文信息 - Subacute cardiotoxicity caused by anthracycline therapy in children: can dexrazoxane prevent this effect? - 字舞流文

Subacute cardiotoxicity caused by anthracycline therapy in children: can dexrazoxane prevent this effect?

Judit Müller | M. Csóka | D. Erdélyi | E. Horvath | Judit Müller | Hajna Erlaky | G. Kovacs | J. Szabolcs | K. Tóth | L. Jókúti

[1] S. Lipshultz. Exposure to anthracyclines during childhood causes cardiac injury. , 2006, Seminars in oncology.

[2] S. Lipshultz,et al. Protecting against anthracycline‐induced myocardial damage: a review of the most promising strategies , 2005, British journal of haematology.

[3] J. Michálek,et al. Long-term serial echocardiographic examination of late anthracycline cardiotoxicity and its prevention by dexrazoxane in paediatric patients , 2005, European Journal of Pediatrics.

[4] Risto S. Cvetković,et al. Dexrazoxane , 2012, Drugs.

[5] P. Voûte,et al. Anthracycline-induced clinical heart failure in a cohort of 607 children: long-term follow-up study. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6] S. Lipshultz,et al. Epidemiology of anthracycline cardiotoxicity in children and adults. , 1998, Seminars in oncology.